ESG Report

Overview

The report presents Ryvu Therapeutics' inaugural ESG disclosure for 2023, covering governance, social, and environmental topics. It reports 276 employees and describes employee-focused initiatives including mandatory antiharassment training and well-being support. Environmental disclosures include 33.1 t of total waste and 3,735 m3 of water consumption, alongside electricity and emissions data. The report also states that no serious or fatal accidents have been recorded in Ryvu's history.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: Ends 31 December 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services